Skip to main content

Idecabtagene vicleucel Pregnancy and Breastfeeding Warnings

Brand names: Abecma

Medically reviewed by Last updated on Jun 5, 2023.

Idecabtagene vicleucel Pregnancy Warnings

Use should be avoided.

US FDA pregnancy category: Not assigned.

Risk Summary: There are no data on the use of this drug in pregnancy. No animal reproductive and developmental toxicity studies have been conducted. It is not known if this drug is transferred to the fetus. Based on the mechanism of action, if the transduced cells cross the placenta, they may cause fetal toxicity, including plasma cell aplasia or hypogammaglobulinemia.

-This drug is not recommended for use in pregnancy.
-Adequate methods of contraception should be encouraged.
-Verify negative pregnancy status in females of reproductive potential prior to initiating therapy.
-If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential harm to the fetus.
-Assess immunoglobulin levels in newborns of mothers treated with this drug.
-There are no data on the effect of this drug on fertility.

Animal studies on this drug have not been conducted. There are no controlled data in human pregnancy.

US FDA pregnancy category Not Assigned: The US FDA has amended the pregnancy labeling rule for prescription drug products to require labeling that includes a summary of risk, a discussion of the data supporting that summary, and relevant information to help health care providers make prescribing decisions and counsel women about the use of drugs during pregnancy. Pregnancy categories A, B, C, D and X are being phased out.

See references

Idecabtagene vicleucel Breastfeeding Warnings

Safety has not been established.

Excreted into human milk: Unknown
Excreted into animal milk: Data not available

-The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. (2021) "Product Information. Abecma (idecabtagene vicleucel)." Celgene Corporation

References for breastfeeding information

  1. (2021) "Product Information. Abecma (idecabtagene vicleucel)." Celgene Corporation

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.